39
|
1 <html>
|
|
2
|
|
3 <head>
|
|
4 <meta http-equiv=Content-Type content="text/html; charset=windows-1252">
|
|
5 <meta name=Generator content="Microsoft Word 14 (filtered)">
|
|
6 <style>
|
|
7 <!--
|
|
8 /* Font Definitions */
|
|
9 @font-face
|
|
10 {font-family:Calibri;
|
|
11 panose-1:2 15 5 2 2 2 4 3 2 4;}
|
|
12 @font-face
|
|
13 {font-family:UICTFontTextStyleBody;}
|
|
14 /* Style Definitions */
|
|
15 p.MsoNormal, li.MsoNormal, div.MsoNormal
|
|
16 {margin-top:0in;
|
|
17 margin-right:0in;
|
|
18 margin-bottom:10.0pt;
|
|
19 margin-left:0in;
|
|
20 line-height:115%;
|
|
21 font-size:11.0pt;
|
|
22 font-family:"Calibri","sans-serif";}
|
|
23 a:link, span.MsoHyperlink
|
|
24 {color:blue;
|
|
25 text-decoration:underline;}
|
|
26 a:visited, span.MsoHyperlinkFollowed
|
|
27 {color:purple;
|
|
28 text-decoration:underline;}
|
|
29 span.apple-converted-space
|
|
30 {mso-style-name:apple-converted-space;}
|
|
31 .MsoChpDefault
|
|
32 {font-family:"Calibri","sans-serif";}
|
|
33 .MsoPapDefault
|
|
34 {margin-bottom:10.0pt;
|
|
35 line-height:115%;}
|
|
36 @page WordSection1
|
|
37 {size:8.5in 11.0in;
|
|
38 margin:1.0in 1.0in 1.0in 1.0in;}
|
|
39 div.WordSection1
|
|
40 {page:WordSection1;}
|
|
41 -->
|
|
42 </style>
|
|
43
|
|
44 </head>
|
|
45
|
|
46 <body lang=EN-US link=blue vlink=purple>
|
|
47
|
|
48 <div class=WordSection1>
|
|
49
|
|
50 <p class=MsoNormalCxSpFirst style='text-align:justify'><b><span lang=EN-GB
|
|
51 style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>References</span></b></p>
|
|
52
|
|
53 <p class=MsoNormalCxSpMiddle style='text-align:justify'><span lang=EN-GB
|
|
54 style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif";
|
|
55 color:black'>Yaari, G. and Uduman, M. and Kleinstein, S. H. (2012). Quantifying
|
|
56 selection in high-throughput Immunoglobulin sequencing data sets. In<span
|
|
57 class=apple-converted-space> </span><em>Nucleic Acids Research, 40 (17),
|
|
58 pp. e134–e134.</em><span class=apple-converted-space><i> </i></span>[</span><span
|
|
59 lang=EN-GB><a href="http://dx.doi.org/10.1093/nar/gks457" target="_blank"><span
|
|
60 style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif";
|
|
61 color:#303030'>doi:10.1093/nar/gks457</span></a></span><span lang=EN-GB
|
|
62 style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif";
|
|
63 color:black'>][</span><span lang=EN-GB><a
|
|
64 href="http://dx.doi.org/10.1093/nar/gks457" target="_blank"><span
|
|
65 style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif";
|
|
66 color:#303030'>Link</span></a></span><span lang=EN-GB style='font-size:12.0pt;
|
|
67 line-height:115%;font-family:"Times New Roman","serif";color:black'>]</span></p>
|
|
68
|
|
69 <p class=MsoNormalCxSpMiddle style='text-align:justify'><b><span lang=EN-GB
|
|
70 style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>Graphs</span></b></p>
|
|
71
|
|
72 <p class=MsoNormalCxSpMiddle style='text-align:justify'><u><span lang=EN-GB
|
|
73 style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>AA
|
|
74 mutation frequency</span></u></p>
|
|
75
|
|
76 <p class=MsoNormalCxSpMiddle style='text-align:justify'><span lang=EN-GB
|
|
77 style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>For
|
|
78 each class, the frequency of replacement mutations at each amino acid position
|
|
79 is shown, which is calculated by dividing the number of replacement mutations
|
|
80 at a particular amino acid position/the number sequences that have an amino
|
|
81 acid at that particular position. Since the length of the CDR1 and CDR2 region
|
|
82 is not the same for every VH gene, some amino acids positions are absent.
|
|
83 Therefore we calculate the frequency using the number of amino acids present at
|
|
84 that that particular location. </span></p>
|
|
85
|
|
86 <p class=MsoNormalCxSpMiddle style='text-align:justify'><u><span lang=EN-GB
|
|
87 style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>Antigen
|
|
88 selection (BASELINe)</span></u></p>
|
|
89
|
|
90 <p class=MsoNormalCxSpMiddle style='text-align:justify'><span lang=EN-GB
|
|
91 style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>Shows
|
|
92 the results of the analysis of antigen selection as performed using BASELINe.
|
|
93 Details on the analysis performed by BASELINe can be found in Yaari et al,
|
|
94 PMID: 22641856. The settings used for the analysis are</span><span lang=EN-GB
|
|
95 style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>:
|
|
96 focused, SHM targeting model: human Tri-nucleotide, custom bounderies. The
|
|
97 custom boundries are dependent on the ‘sequence starts at filter’. </span></p>
|
|
98
|
|
99 <p class=MsoNormalCxSpMiddle style='line-height:normal'><span lang=NL
|
|
100 style='font-family:UICTFontTextStyleBody;color:black'>Leader:
|
|
101 1:26:38:55:65:104:-</span></p>
|
|
102
|
|
103 <p class=MsoNormalCxSpMiddle style='line-height:normal'><span lang=NL
|
|
104 style='font-family:UICTFontTextStyleBody;color:black'>FR1: 27:27:38:55:65:104:-</span></p>
|
|
105
|
|
106 <p class=MsoNormalCxSpMiddle style='line-height:normal'><span lang=NL
|
|
107 style='font-family:UICTFontTextStyleBody;color:black'>CDR1: 27:27:38:55:65:104:-</span></p>
|
|
108
|
|
109 <p class=MsoNormalCxSpLast style='line-height:normal'><span lang=NL
|
|
110 style='font-family:UICTFontTextStyleBody;color:black'>FR2: 27:27:38:55:65:104:-</span></p>
|
|
111
|
|
112 <p class=MsoNormal><span lang=NL style='font-size:12.0pt;line-height:115%;
|
|
113 font-family:"Times New Roman","serif"'>Hanna IJspeert, Pauline A. van
|
|
114 Schouwenburg, David van Zessen, Ingrid Pico-Knijnenburg, Gertjan J. Driessen,
|
|
115 Andrew P. Stubbs, and Mirjam van der Burg (2016). </span><span
|
|
116 style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>Evaluation
|
|
117 of the Antigen-Experienced B-Cell Receptor Repertoire in Healthy Children and
|
|
118 Adults. In <i>Frontiers in Immunolog, 7, pp. e410-410. </i>[<a
|
|
119 href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5066086/"><span
|
|
120 style='color:windowtext'>doi:10.3389/fimmu.2016.00410</span></a>][<a
|
|
121 href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5066086/"><span
|
|
122 style='color:windowtext'>Link</span></a>]</span></p>
|
|
123
|
|
124 </div>
|
|
125
|
|
126 </body>
|
|
127
|
|
128 </html>
|